PRECISIONvalue
PRECISIONvalue (branded as Precision AQ) is a B2B healthcare consulting and technology firm serving pharmaceutical and biotechnology companies with market access, HEOR, medical communications, brand strategy, investor relations, and proprietary data-driven products including AccessGenius and OncoGenius, operating as a subsidiary of Precision Medicine Group.
- Company typePrivate
- Founded2014
- HeadquartersNew York, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What PRECISIONvalue does
PRECISIONvalue, operating under the brand Precision AQ, is a B2B healthcare consulting and technology firm serving pharmaceutical and biotechnology companies across the commercialization lifecycle. Founded in 2014 and headquartered in New York, the firm focuses on market access, HEOR evidence generation, payer strategy, medical communications, brand strategy, investor relations, and data analytics for pharma and biotech leaders. Company-stated metrics indicate involvement with launches representing 25% of all FDA-approved drugs in 2024, with multiple launches and label expansions supported annually. PRECISIONvalue operates as a subsidiary of Precision Medicine Group, evidenced by shared privacy policy and ESG infrastructure hosted on precisionmedicinegrp.com. The firm maintains therapeutic expertise across five specialty areas — immunology, neurology, oncology, rare disease, and cardio renal metabolic — supported by a UK office serving European markets.
The company's offerings combine professional services with a five-product technology suite. Services span Value & Access (access consulting, HEOR, market access agency), Medical Communications (peer-to-peer marketing, medical affairs, learning & development), Investor Relations & External Communications, Brand Strategy & Marketing (advertising, data insights), and Data, Insights & Analytics across patient, payer, and provider segments. The technology portfolio includes AccessGenius (payer strategy and market potential evaluation), OncoGenius (oncology-specific targeting), Data Solutions (HCP/payer/patient engagement analytics), EHR Solutions (electronic health record integration), and Omnichannel Solutions (multichannel engagement). Proprietary features span domain specialization (AccessGenius, OncoGenius), integration and interoperability (EHR Solutions, Omnichannel Solutions), and data scale (Data Solutions).
PRECISIONvalue's business model combines enterprise project-based and retainer professional services engagements with subscription or recurring revenue from its proprietary technology products. The go-to-market is direct enterprise field sales targeting pharmaceutical and biotechnology commercial leaders, medical affairs teams, and market access professionals. Pricing is quote-based given the enterprise B2B professional services nature, with no publicly disclosed pricing tiers. With employee headcount in the 501–1,000 range, the firm operates at mid-to-large scale within pharma commercialization services, supported by leadership including C-suite executives such as Chief Operating Officer Carlos Delucca.
PRECISIONvalue firmographics
Firmographics- Name
- PRECISIONvalue
- Legal name
- Precision AQ
- Website
- https://precisionvalue.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- PRECISIONvalue (branded as Precision AQ) is a B2B healthcare consulting and technology firm serving pharmaceutical and biotechnology companies with market access, HEOR, medical communications, brand strategy, investor relations, and proprietary data-driven products including AccessGenius and OncoGenius, operating as a subsidiary of Precision Medicine Group.
- Ownership category
- akta.pro rank
PRECISIONvalue industry classification
Industry- Product category
- Pharmaceutical Market Access Consulting
- NAICS
- Other Scientific and Technical Consulting Services (54169), Computer Systems Design and Related Services (54151)
- akta.pro primary industry
- Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB)
- akta.pro secondary industries
- Regulatory Affairs & Submissions FSP (HLAGAOAD), Clinical Decision Support & Workflow Integration (EHR/oncology systems) (HLAAANAE)
Keywords
Where PRECISIONvalue is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
PRECISIONvalue business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Professional Consulting Services: Advisory and consulting services for pharma and biotech companies covering market access strategy, HEOR evidence generation, payer strategy, medical communications, brand strategy, investor relations, and data analytics. Services appear to be project-based or retainer engagements with enterprise pharmaceutical clients.
- Software Products and Data Solutions: Proprietary technology products including AccessGenius, OncoGenius, EHR Solutions, and Data Solutions sold to pharmaceutical clients for market potential evaluation, targeting, and commercial impact support.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
PRECISIONvalue product offering
Product offeringCore offering
PRECISIONvalue (operating commercially as Precision AQ) is a market access and commercialization partner for pharmaceutical and biotech companies. It integrates technology, expertise, and strategy to help clients generate HEOR evidence, execute payer strategy and payer marketing, support medical communications and medical affairs, manage investor relations and public relations, and deliver brand strategy and marketing. The firm complements consulting with five proprietary technology products—AccessGenius, OncoGenius, Data Solutions, EHR Solutions, and Omnichannel Solutions—for HCP, payer, and patient engagement.
Product overview
Precision AQ is a market access and commercialization partner for pharma and biotech companies, offering a suite of five interconnected products: AccessGenius (payer strategy and market access), OncoGenius (oncology-focused targeting), Data Solutions (patient, payer, and provider data analytics), EHR Solutions (electronic health record integration), and Omnichannel Solutions (multichannel engagement). These products are complemented by consulting services in Value & Access, HEOR, Medical Communications, Brand Strategy & Marketing, and Data, Insights, & Analytics.
Differentiator
Problem solved
Functional benefit
Brands
- AccessGenius: Product offering in the product offerings suite
- OncoGenius
- Data Solutions
- EHR Solutions
- Omnichannel Solutions
Products and services
- AccessGenius Market access product designed to evaluate market potential and support commercial impact through payer strategy and payer marketing for pharmaceutical clients.
- OncoGenius Oncology-focused product that streamlines targeting and supports commercial impact for oncology treatments in the pharmaceutical market.
- Data Solutions Data solutions product that powers HCP (healthcare professional), payer, and patient engagement by evaluating market potential and supporting commercial impact through analytics.
Quantifiable outcome
- 25% of all FDA-approved drugs in 2024 were launched with Precision AQ as agency of record
Companies that use PRECISIONvalue
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles1 record
PRECISIONvalue technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
PRECISIONvalue partnerships and signals
Strategic signalScale indicators3 records
Recent moves4 records
Expansion highlights5 records
PRECISIONvalue competitors and assessment
Company assessmentDirect peers
- ZS Associates: Global consulting firm specializing in pharma sales, marketing, and market access strategy with deep data/analytics capabilities. Overlaps with Precision AQ's payer strategy, HEOR, and data solutions offerings targeting the same pharma/biotech enterprise clients.
- Avalere Health: Healthcare consulting firm providing market access, HEOR, and policy advisory services to pharma/biotech. Closely comparable in market access and payer strategy focus serving enterprise pharmaceutical clients.
- Beghou Consulting: Pharma commercial consulting firm focused on sales, marketing, market access, and advanced analytics for life sciences clients. Highly comparable boutique competitor to Precision AQ in market access and HEOR consulting.
- Trinity Life Sciences: Strategy and insights consultancy serving pharma/biotech with commercial strategy, HEOR, market access, and data analytics. Direct peer to Precision AQ given overlapping service lines and target customers in pharmaceutical commercialization.
- Eversana: Integrated commercial services platform serving pharma/biotech with market access, HEOR, patient services, and data analytics. Most directly comparable to Precision AQ given its end-to-end commercialization focus and similar customer base of enterprise pharma clients.
Broad incumbents
- IQVIA: Global leader in life sciences analytics, technology, and contract services with deep market access, HEOR, and commercialization capabilities. A broad incumbent that overlaps with most of Precision AQ's offerings at much larger scale.
- Health Strategies Group (a division of Eversana): Specialty pharma market access consultancy within Eversana providing payer strategy and access services. Comparable in payer/market access focus but operates within a much larger parent platform.
- Fishawack Health (now part of Avalere/Fishawack): Global healthcare communications and consulting firm offering medical communications, market access, and HEOR services to pharma. Comparable in service mix to Precision AQ's Medical Communications and Value & Access practices.
- Syneos Health (private, Elliott Management): End-to-end biopharmaceutical solutions organization providing clinical and commercial services. Comparable in commercialization services targeting pharma, though Syneos operates at substantially greater scale and breadth.
Others
- PRECISIONeffect (within Precision Medicine Group): Sister agency within Precision Medicine Group providing advertising, branding, and marketing communications for pharma. Closely adjacent as a sibling entity under the same parent conglomerate, sharing clients and infrastructure.
Market position
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
PRECISIONvalue social profiles
Digital presencePRECISIONvalue financial estimates
Financial estimateRevenue estimate
Valuation estimate
PRECISIONvalue leadership team
Management profileNumber of profiles
Profiles1 record
PRECISIONvalue funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PRECISIONvalue M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PRECISIONvalue
What does PRECISIONvalue do?
PRECISIONvalue (operating commercially as Precision AQ) is a market access and commercialization partner for pharmaceutical and biotech companies. It integrates technology, expertise, and strategy to help clients generate HEOR evidence, execute payer strategy and payer marketing, support medical communications and medical affairs, manage investor relations and public relations, and deliver brand strategy and marketing. The firm complements consulting with five proprietary technology products—AccessGenius, OncoGenius, Data Solutions, EHR Solutions, and Omnichannel Solutions—for HCP, payer, and patient engagement.
Is PRECISIONvalue a public or private company?
PRECISIONvalue is a private company. It is classified as corporate owned and is currently operating.
When was PRECISIONvalue founded?
PRECISIONvalue was founded in 2014. It employs 501 to 1,000 people.
Where is PRECISIONvalue based?
PRECISIONvalue is headquartered in New York, United States, in the North America region.
How does PRECISIONvalue make money?
Two revenue lines are on record. Professional Consulting Services are the primary driver. The others are software Products and Data Solutions.
Who are PRECISIONvalue's main competitors?
Direct peers on record are ZS Associates, Avalere Health, Beghou Consulting, Trinity Life Sciences and Eversana. Broad incumbents are IQVIA, Health Strategies Group (a division of Eversana), Fishawack Health (now part of Avalere/Fishawack) and Syneos Health (private, Elliott Management). PRECISIONeffect (within Precision Medicine Group) is listed as an others.
Does PRECISIONvalue have an API?
No public API is recorded for PRECISIONvalue.
What industry is PRECISIONvalue in?
PRECISIONvalue's product category is Pharmaceutical Market Access Consulting. Its primary akta.pro industry code is HLAGAOAB, Data Management, Biostatistics & Statistical Programming FSP, with a secondary code of HLAGAOAD, Regulatory Affairs & Submissions FSP. Its NAICS code is 54169.